Chronic Lymphocytic Leukemia (CLL) Bone Marrow Mononuclear Cells

Chronic Lymphocytic Leukemia (CLL) Bone Marrow Mononuclear Cells for Leukemia Research

Our Chronic Lymphocytic Leukemia (CLL) Bone Marrow Mononuclear Cells is a hematopoietic tissue sample isolated by density-gradient separation from bone marrow aspirate, capturing the full spectrum of marrow-resident hematopoietic stem, progenitor, and precursor cells that peripheral blood samples do not contain. Samples are sourced from IRB-consented donors clinically diagnosed with CLL, a chronic lymphoproliferative disorder with marrow involvement.

CLL Biology and Why Bone Marrow

• CLL is characterized by clonal accumulation of mature-appearing B lymphocytes, and while diagnosis is often made from peripheral blood, marrow biopsy remains important for confirming diagnosis, evaluating cytopenias, and assessing disease burden.
• The pattern of marrow infiltration – nodular, interstitial, or diffuse – carries independent prognostic value, with diffuse infiltration associated with more advanced disease and marrow failure.
• IGHV mutation status and cytogenetic abnormalities (including del(17p) and del(11q)) are key prognostic and predictive markers assessed alongside marrow and peripheral blood studies.
• The marrow microenvironment, including stromal and nurse-like cells, supports CLL cell survival and is an active target of research into disease persistence and drug resistance.
• Targeted therapies including BTK inhibitors and BCL-2 inhibitors have created demand for marrow-derived material in pharmacodynamic and resistance studies.

Donor Stratification Available

• IGHV mutation status where documented
• Cytogenetic abnormalities, including del(17p) and del(11q)
• Marrow infiltration pattern where documented
• Disease stage (Rai/Binet) and treatment history
• Age band and sex assigned at birth
• Matched healthy bone marrow controls available

Product Features

• Isolated from clinically confirmed CLL donor bone marrow aspirate
• Density-gradient purified and cryopreserved
• Research Use Only (RUO)
• IRB-approved protocols with documented consent
• Standard and custom cell quantities available

De-identified Donor Data

• CLL diagnosis confirmation and cytogenetic subtype where documented
• Age, sex assigned at birth, and ethnicity
• Donor-reported allergy and infectious disease history
• Disease stage and treatment history where documented
• Additional CLL-specific metadata available on request

Applications

• Marrow microenvironment and stromal interaction studies
• IGHV and cytogenetic prognostic marker studies
• BTK inhibitor and BCL-2 inhibitor pharmacodynamic and resistance research
• Disease burden and infiltration pattern studies
• Immunophenotyping and biomarker discovery

Other Specimen Types

For matched marrow-derived material across conditions, see our human bone marrow mononuclear cells collection.

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11-compliant e-signatures
• Documentation support available for regulatory review

Ordering & Customization

CLL bone marrow mononuclear cells are available in standard and custom cell quantities. For pricing, international orders, or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.